“The lawsuit Trump has brought today against CBS is completely without merit and we will vigorously defend against it.” As a legal matter, the idea that CBS News engaged in “election ...
Students living in an Ohio State University dormitory where black mold and mushrooms were found growing will have a new ...
Concerns of mold and mushrooms in an Ohio State freshman residence hall are growing. The university said a water leak is to ...
Builders, insurance industry groups and other businesses on Thursday blamed overzealous lawyers and increased media attention for a threefold increase in mold-related lawsuits the past three years.
Mold is a type of fungus that tends to grow on kitchen tiles, bathroom walls and other damp surfaces in our homes. Just like other fungal species, it spreads through spores — tiny 'seeds' that ...
She alleges that inspectors told her things were pretty much good to go, but mold inside made her sick, while flooding issues and crumbling walls have led to a lawsuit. “This is where most of ...
Pocketpair, the developer of Palworld, has published details on the lawsuit filed against it by The Pokémon Company and Nintendo in Japan, listing the patents it’s being accused of infringing ...
Missouri's abortion ban faces a new lawsuit after voters on Tuesday approved a ballot measure that could roll back the current ban on abortions. In a sweeping move following Tuesday's election ...
In June, nine tenants sued Columbus Property Management & Development, accusing the company of failing to maintain three of its apartment complexes and allowing conditions that included mold, leaks, ...
Former presidents of the American Bar Association and other state and local bar associations published an open letter condemning election lawsuits brought forth in swing states across the country.
There have been thousands of lawsuits filed against drug distributors, pharmacies and wholesalers for contributing to the opioid crisis. Over the past eight years, communities have settled for ...
In a series of lawsuits filed this year, Novartis has alleged that several rivals have infringed on patents for one or both of its commercial radioligand therapies Pluvicto and Lutathera.